Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
ML

Malin Lemurell — 13 Patents

Astrazeneca Ab: 12 patents #60 of 1,971Top 4%
AAAlbireo Ab: 1 patents #26 of 43Top 65%
Mölndal, SE: #48 of 860 inventorsTop 6%
Overall (All Time): #362,438 of 4,157,543Top 9%
13 Patents All Time
Malin Lemurell has been granted 13 US patents while listed as an inventor at Astrazeneca Ab. The first was granted in 2006 and the most recent in July 2024. Malin Lemurell ranks #362,438 of 4,157,543 US inventors in our database (top 8.7%). Patent records list Malin Lemurell in Mölndal, SE.

Issued Patents All Time

Showing 1–13 of 13 patents

Patent #TitleCo-InventorsDateApprox Value ⓘ
12024523 Pyrazole derivatives useful as 5-lipoxygenase activating protein (FLAP) inhibitors Johan Olof Broddefalk, Hans Emtenas, Kenneth Granberg, Daniel Tor Pettersen, Alleyn Thomas Plowright +1 more 2024-07-02 $112,383,000
11691978 Pyrazole derivatives useful as 5-lipoxygenase activating protein (FLAP) inhibitors Johan Olof Broddefalk, Hans Emtenas, Kenneth Granberg, Daniel Tor Pettersen, Alleyn Thomas Plowright +1 more 2023-07-04
11001589 Pyrazole derivatives useful as 5-lipoxygenase activating protein (FLAP) inhibitors Johan Olof Broddefalk, Hans Emtenas, Kenneth Granberg, Daniel Tor Pettersen, Alleyn Thomas Plowright +1 more 2021-05-11 $72,048,000
10508119 Pyrazole derivatives useful as 5-lipdxygenase activating protein (FLAP) inhibitors Johan Olof Broddefalk, Hans Emtenas, Kenneth Granberg, Daniel Tor Pettersen, Alleyn Thomas Plowright +1 more 2019-12-17 $123,134,000
10183947 Pyrazole derivatives useful as 5-lipoxygenase activating protein (FLAP) inhibitors Johan Olof Broddefalk, Hans Emtenas, Kenneth Granberg, Daniel Tor Pettersen, Alleyn Thomas Plowright +1 more 2019-01-22 $38,184,000
8067584 Benzothiazepine derivatives Ingemar Starke, Suzanne Alenfalk, Mats Peter Nordberg, Mikael Dahlstrom, Stig Jonas Bostrom +1 more 2011-11-29
7893048 2-azetidinone derivatives as cholesterol absorption inhibitors for the treatment of hyperlipidaemic conditions Susanne Alenfalk, Mikael Dahlstrom, Fana Hunegnaw, Staffan Po Karlsson, Ingemar Starke 2011-02-22 $12,774,000
7871998 Diphenylazetidinone derivatives possessing cholesterol absorption inhibitory activity Susanne Alenfalk, Mikael Dahlstrom, Fana Hunegnaw, Staffan Po Karlsson, Ann-Margret Lindqvist +2 more 2011-01-18 $8,468,000
7863265 2-azetidinone derivatives and their use as cholesterol absorption inhibitors for the treatment of hyperlipidaemia Susanne Alenfalk, Mikael Dahlstrom, Fana Hunegnaw, Staffan Po Karlsson, Ann-Margret Lindqvist +2 more 2011-01-04 $13,113,000
7842684 Diphenylazetidinone derivatives possessing cholesterol absorption inhibitor activity Ingemar Starke 2010-11-30 $3,905,000
7470678 Diphenylazetidinone derivatives for treating disorders of the lipid metabolism Ingemar Starke, Mikael Dahlstrom, Ann-Margret Lindqvist, Mats Peter Nordberg, Tore Skjaret 2008-12-30 $35,068,000
7192947 Peptides derivatives comprising thiazepine group for the treatment of hyperlipidemic conditions Ingemar Starke, Mikael Dahlstrom, Suzanne Alenfalk, Tore Skjaret 2007-03-20 $7,751,000
7132416 Benzothiazepine and benzothiazepine derivatives with ileal bile acid transport (IBAT) inhibotory activity for the treatment hyperlipidaemia Ingemar Starke, Mikael Dahlstrom, David Blomberg, Suzanne Alenfalk, Tore Skjaret 2006-11-07 $11,413,000